Windlas Biotech Limited (NSE:WINDLAS)

Windlas Biotech Revenue

In the fiscal year ending March 31, 2026, Windlas Biotech had annual revenue of 9.04B INR with 18.98% growth. Windlas Biotech had revenue of 2.38B in the quarter ending March 31, 2026, with 17.66% growth.

• Revenue: 9.04B
• Revenue Growth: +18.98%
• P/S Ratio: 1.90
• Revenue / Employee: n/a
• Employees: 1,346
• Market Cap: 17.16B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	9.04B	1.44B	18.98%
Mar 31, 2025	7.60B	1.29B	20.43%
Mar 31, 2024	6.31B	1.18B	22.97%
Mar 31, 2023	5.13B	471.53M	10.12%
Mar 31, 2022	4.66B	383.28M	8.96%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 1, 2026

Data Sources Report a data error